Nature Search

Erratum: BAP1 loss defines a new class of renal cell carcinoma

Samuel Peña-Llopis
Silvia Vega-Rubín-de-Celis
James Brugarolas
Amendments and Corrections29 Aug 2012
Nature Genetics

Volume: 44, P: 1072
Author Correction: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2

Jing Y. Krzeszinski
Wei Wei
Yihong Wan
Amendments and Corrections24 May 2019
Nature

Volume: 570, P: E51
Retraction Note: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2

Jing Y. Krzeszinski
Wei Wei
Yihong Wan
Amendments and Corrections01 Jun 2020
Nature

Volume: 582, P: 134
Synthetic lethal screen identification of chemosensitizer loci in cancer cells

Angelique W. Whitehurst
Brian O. Bodemann
Michael A. White
Research12 Apr 2007
Nature

Volume: 446, P: 815-819
Comprehensive functional characterization of cancer–testis antigens defines obligate participation in multiple hallmarks of cancer

Proteins usually expressed solely in the testes are often found over-expressed in cancer and are termed cancer testis antigens. Here, the authors use a comprehensive screening strategy to identify 26 cancer-testis antigens that promote tumorigenic behaviour.

Kimberly E. Maxfield
Patrick J. Taus
Angelique W. Whitehurst
ResearchOpen Access16 Nov 2015
Nature Communications

Volume: 6, P: 1-15
A transistor-like pH nanoprobe for tumour detection and image-guided surgery

A fluorescent nanoprobe that amplifies the fluorescent signal in a broad range of tumours allows for real-time tumour-acidosis-guided detection and surgery of occult, less-than-1-mm³ nodules in mice bearing head and neck or breast tumours.

Tian Zhao
Gang Huang
Jinming Gao
Research19 Dec 2016
Nature Biomedical Engineering

Volume: 1, P: 1-8
The role of Nasoalveolar molding: A 3D Prospective analysis

Pang-Yun Chou
Rami R. Hallac
Yong Jong Park
ResearchOpen Access29 Aug 2017
Scientific Reports

Volume: 7, P: 1-8
Targeting renal cell carcinoma with a HIF-2 antagonist

The HIF-2 antagonist PT2399 is tested in mice bearing tumourgrafts derived from human renal cell cancers to demonstrate its efficacy, identify markers of sensitivity and characterize its effects.

Wenfang Chen
Haley Hill
James Brugarolas
Research05 Sept 2016
Nature

Volume: 539, P: 112-117
BAP1 loss defines a new class of renal cell carcinoma

James Brugarolas and colleagues identify recurrent BAP1 mutations in clear cell renal cell carcinoma (ccRCC). They show that BAP1 binds to HCF-1 and suppresses cell proliferation, and they find that BAP1 loss is associated with high tumor grade.

Samuel Peña-Llopis
Silvia Vega-Rubín-de-Celis
James Brugarolas
Research10 Jun 2012
Nature Genetics

Volume: 44, P: 751-759
RETRACTED ARTICLE: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2

A microRNA, miR-34a, is a novel and critical suppressor of osteoclastogenesis, bone resorption and the bone metastatic niche.

Jing Y. Krzeszinski
Wei Wei
Yihong Wan
Research25 Jun 2014
Nature

Volume: 512, P: 431-435
Identification and Characterization of a Suite of Tumor Targeting Peptides for Non-Small Cell Lung Cancer

Michael J. McGuire
Bethany Powell Gray
Kathlynn C. Brown
ResearchOpen Access27 Mar 2014
Scientific Reports

Volume: 4, P: 1-11

Search

Filter By:

Search

Quick links